First Patient Treated with Proton Therapy at Lynn Cancer Institute - Scorecard - MDSpire

First Patient Treated with Proton Therapy at Lynn Cancer Institute

The Eugene M. & Christine E. Lynn Cancer Institute at Boca Raton Regional Hospital, part of Baptist Health, reached an important milestone in the advancement of cancer care with the successful treatment of its first patient utilizing proton therapy, according to physicians at both the Institute and the hospital.

  • May 15, 2026

  • 5 min

Share

Clinical Scorecard: First Patient Treated with Proton Therapy at Lynn Cancer Institute

At a Glance

CategoryDetail
ConditionCancer
Key MechanismsProton therapy uses a beam of protons to precisely target tumors while minimizing radiation exposure to surrounding healthy tissue.
Target PopulationPatients with tumors located near sensitive organs or critical structures, including brain, spine, head and neck, thoracic, and pediatric cancers.
Care SettingLynn Cancer Institute, part of Baptist Health

Key Highlights

  • First patient treated with proton therapy at Lynn Cancer Institute.
  • Proton therapy offers highly targeted radiation treatment.
  • Collaboration between multidisciplinary teams enhances patient care.
  • Philanthropic support enabled the establishment of the Proton Therapy Center.
  • Focus on personalized care and improved patient outcomes.

Guideline-Based Recommendations

Diagnosis

  • Clinical evaluation to determine suitability for proton therapy.

Management

  • Utilize a multidisciplinary team for treatment planning.

Monitoring & Follow-up

  • Regular follow-ups to assess treatment effectiveness and patient well-being.

Risks

  • Consideration of potential risks associated with radiation exposure to surrounding tissues.

Patient & Prescribing Data

Patients with specific cancer types requiring targeted radiation therapy.

Proton therapy is particularly beneficial for tumors near critical structures.

Clinical Best Practices

  • Engage in collaborative decision-making among specialists.
  • Ensure comprehensive patient evaluation before treatment initiation.
  • Maintain open communication with patients regarding treatment options and outcomes.

Related Resources & Content

Original Source(s)

First Patient Treated with Proton Therapy at Lynn Cancer Institute

  • May 15, 2026

Related Content

This Week's CGT News: First Treg Therapy Approved

First Treg-based cell therapy approved, FDA advanced therapy office faces fresh turnover, and preclinical CAR T studies target rare blood cancers and glioblastoma

  • July 7, 2026

  • 6 min
cfDNA’s Big Moment Has Arrived

Experts explore the promise, pitfalls, and future of cfDNA testing in modern laboratory medicine

ESMO Breast Cancer 2026 Highlights Panel Discussion

Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Erica L. Mayer, MD, MPH; Nancy Lin, MD; and Ana C. Garrido-Castro, MD discuss important breast cancer research presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min